Schedule 13G/A
INSM Schedule 13G/A filing by JPMorgan Chase / Asset Management
JPMorgan Chase / Asset Management reported beneficial ownership of 23.0M shares, representing 12% of INSMED INC in this filing.
FiledSep 4, 2025
Ownership dateAug 29, 2025
Reported shares23.0M
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
21.0M
Shared voting power
23.0M
Sole dispositive power
23.0M
Shared dispositive power
23.0M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$142.53as of Sep 4, 2025
Latest tracked price$99.79as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- JPMorgan Chase / Asset Management
- CIK
- CIK0000019617
- Accession
- 0000019617-25-000748
- Form
- Schedule 13G/A
Read the filing in context